Annual CFF:
$76.68M-$59.71M(-43.78%)Summary
- As of today, TSHA annual cash from financing is $76.68 million, with the most recent change of -$59.71 million (-43.78%) on December 31, 2024.
- During the last 3 years, TSHA annual cash from financing has risen by +$37.60 million (+96.21%).
- TSHA annual cash from financing is now -73.65% below its all-time high of $291.06 million, reached on December 31, 2020.
Performance
TSHA Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFF:
$8.80M-$207.49M(-95.93%)Summary
- As of today, TSHA quarterly cash from financing is $8.80 million, with the most recent change of -$207.49 million (-95.93%) on September 30, 2025.
- Over the past year, TSHA quarterly cash from financing has increased by +$2.20 million (+33.39%).
- TSHA quarterly cash from financing is now -95.93% below its all-time high of $216.29 million, reached on June 30, 2025.
Performance
TSHA Quarterly Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
$224.66M+$2.20M(+0.99%)Summary
- As of today, TSHA TTM cash from financing is $224.66 million, with the most recent change of +$2.20 million (+0.99%) on September 30, 2025.
- Over the past year, TSHA TTM cash from financing has increased by +$151.85 million (+208.55%).
- TSHA TTM cash from financing is now at all-time high.
Performance
TSHA TTM Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
TSHA Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -43.8% | +33.4% | +208.6% |
| 3Y3 Years | +96.2% | +8640.8% | +1025.0% |
| 5Y5 Years | +100.0% | - | - |
TSHA Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -43.8% | +96.2% | -95.9% | +307.1% | at high | +1025.0% |
| 5Y | 5-Year | -73.7% | >+9999.0% | -95.9% | +307.1% | at high | >+9999.0% |
| All-Time | All-Time | -73.7% | >+9999.0% | -95.9% | +307.1% | at high | >+9999.0% |
TSHA Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $8.80M(-95.9%) | $224.66M(+1.0%) |
| Jun 2025 | - | $216.29M(>+9900.0%) | $222.46M(+190.3%) |
| Mar 2025 | - | -$52.00K(+86.1%) | $76.64M(-0.1%) |
| Dec 2024 | $76.68M(-43.8%) | -$375.00K(-105.7%) | $76.68M(+5.3%) |
| Sep 2024 | - | $6.59M(-90.6%) | $72.81M(-64.8%) |
| Jun 2024 | - | $70.47M(>+9900.0%) | $206.85M(+51.3%) |
| Mar 2024 | - | -$4000.00(+99.9%) | $136.76M(+0.3%) |
| Dec 2023 | $136.39M(+161.8%) | -$4.25M(-103.0%) | $136.39M(-25.0%) |
| Sep 2023 | - | $140.63M(>+9900.0%) | $181.87M(+342.1%) |
| Jun 2023 | - | $377.00K(+201.9%) | $41.14M(-20.6%) |
| Mar 2023 | - | -$370.00K(-100.9%) | $51.83M(-0.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | $52.10M(+33.3%) | $41.23M(>+9900.0%) | $52.10M(+160.9%) |
| Sep 2022 | - | -$103.00K(-100.9%) | $19.97M(-60.1%) |
| Jun 2022 | - | $11.07M(>+9900.0%) | $50.05M(+28.4%) |
| Mar 2022 | - | -$107.00K(-101.2%) | $38.98M(-0.3%) |
| Dec 2021 | $39.08M(-86.6%) | $9.11M(-69.6%) | $39.08M(+37.4%) |
| Sep 2021 | - | $29.98M(>+9900.0%) | $28.44M(+1944.1%) |
| Jun 2021 | - | $0.00(0.0%) | -$1.54M(0.0%) |
| Mar 2021 | - | $0.00(+100.0%) | -$1.54M(-109.4%) |
| Dec 2020 | $291.06M(>+9900.0%) | - | - |
| Dec 2020 | - | -$1.54M(-108.6%) | $16.48M(-8.6%) |
| Mar 2020 | - | $18.03M | $18.03M |
| Dec 2019 | $0.00 | - | - |
FAQ
- What is Taysha Gene Therapies, Inc. annual cash from financing?
- What is the all-time high annual cash from financing for Taysha Gene Therapies, Inc.?
- What is Taysha Gene Therapies, Inc. annual cash from financing year-on-year change?
- What is Taysha Gene Therapies, Inc. quarterly cash from financing?
- What is the all-time high quarterly cash from financing for Taysha Gene Therapies, Inc.?
- What is Taysha Gene Therapies, Inc. quarterly cash from financing year-on-year change?
- What is Taysha Gene Therapies, Inc. TTM cash from financing?
- What is the all-time high TTM cash from financing for Taysha Gene Therapies, Inc.?
- What is Taysha Gene Therapies, Inc. TTM cash from financing year-on-year change?
What is Taysha Gene Therapies, Inc. annual cash from financing?
The current annual cash from financing of TSHA is $76.68M
What is the all-time high annual cash from financing for Taysha Gene Therapies, Inc.?
Taysha Gene Therapies, Inc. all-time high annual cash from financing is $291.06M
What is Taysha Gene Therapies, Inc. annual cash from financing year-on-year change?
Over the past year, TSHA annual cash from financing has changed by -$59.71M (-43.78%)
What is Taysha Gene Therapies, Inc. quarterly cash from financing?
The current quarterly cash from financing of TSHA is $8.80M
What is the all-time high quarterly cash from financing for Taysha Gene Therapies, Inc.?
Taysha Gene Therapies, Inc. all-time high quarterly cash from financing is $216.29M
What is Taysha Gene Therapies, Inc. quarterly cash from financing year-on-year change?
Over the past year, TSHA quarterly cash from financing has changed by +$2.20M (+33.39%)
What is Taysha Gene Therapies, Inc. TTM cash from financing?
The current TTM cash from financing of TSHA is $224.66M
What is the all-time high TTM cash from financing for Taysha Gene Therapies, Inc.?
Taysha Gene Therapies, Inc. all-time high TTM cash from financing is $224.66M
What is Taysha Gene Therapies, Inc. TTM cash from financing year-on-year change?
Over the past year, TSHA TTM cash from financing has changed by +$151.85M (+208.55%)